Team:KULeuven/Freezer

From 2009.igem.org

(Difference between revisions)
(vanillin synthesis)
(Blue light receptor)
Line 47: Line 47:
|-
|-
| {{kulpart|BBa_J23101}}(B)||||constitutive promotor||restriction digest with EcoRI en SpeI|| 10μl ||12,8ng/μl||aug 24
| {{kulpart|BBa_J23101}}(B)||||constitutive promotor||restriction digest with EcoRI en SpeI|| 10μl ||12,8ng/μl||aug 24
 +
|-
 +
| {{kulpart|BBa_K238013}}+{{kulpart|BBa_E0240}}||pSB1A2||LigA (1): Exact blue light promotor ligated with E0240 in pSB1A2 ||Miniprep|| 45μl||110,6ng/μl||aug 31
 +
|-
 +
| {{kulpart|BBa_K238013}}+{{kulpart|BBa_E0240}}||pSB1A2||LigA (2): Exact blue light promotor ligated with E0240 in pSB1A2 ||Miniprep|| 43μl||76,7ng/μl||aug 31
 +
|-
 +
| {{kulpart|BBa_K238013}}+{{kulpart|BBa_E0240}}||pSB1A2||LigA (3): Exact blue light promotor ligated with E0240 in pSB1A2 ||Miniprep|| 44μl||84,8ng/μl||aug 31
 +
|-
 +
| {{kulpart|BBa_K238013}}+{{kulpart|BBa_E0240}}||pSB1A2||LigA (4): Exact blue light promotor ligated with E0240 in pSB1A2 ||Miniprep|| 34μl||31,7ng/μl||aug 31
 +
|-
 +
| {{kulpart|BBa_E0240}}||pSB1A2||RBS + GFP + terminator||Miniprep||45μl||104,3ng/μl||aug 31
|}
|}

Revision as of 09:49, 31 August 2009

Contents

Blue light receptor

part plasmid description status μl left concentration date
MC4100 / strain of E.coli july 24
2260 / forward primer for 42,5µl 20μM aug 10
2261 / reverse primer for 45µl 20μM aug 10
pSB1A2GFP + rbs + terminatorMiniprepped100μl85,6ng/μljuly 29
pSB1A2GFP + rbs + terminatorrestricted with EcoRI and XbaI 20μl july 29
pSB1A2GFP + LVA-tag + terminatorrestricted with EcoRI and XbaI30μl29,3 ng/μl aug 14
pSB3K3 kanamycine plasmide backbone taken from plates 13μl aug 11
/Exact blue light promotor pcr product 20μl 123,3 ng/μl aug 13
/constitutive promotortaken from plates 13μl aug 11
/Exact blue light promotor cut with EcoRI and SpeI 26μl 27 ng/μl aug 12
+pSB1A3LigA: Exact blue light promotor ligated with E0240 in pSB1A2 T4 DNA ligation 18μl aug 13
+pSB1A3Lig B: Exact blue light promotor ligated with K145015 in pSB1A2 T4 DNA ligation 18μl aug 14
+/Lig A: Exact blue light promotor ligated with E02040 in pSB1A2 (1,3,7,9) cut with EcoRI and PstI 4 x 18μl aug 24
+pSB1A2LigA: Exact blue light promotor ligated with E0240 in pSB1A2 Miniprep (4x) 20μl aug 18
pSB1A3constitutive promotorminiprep10μl141,2ng/μlaug 14
(A)constitutive promotorrestriction digest with EcoRI en SpeI 20μl 20,8ng/μlaug 24
(B)constitutive promotorrestriction digest with EcoRI en SpeI 10μl 12,8ng/μlaug 24
+pSB1A2LigA (1): Exact blue light promotor ligated with E0240 in pSB1A2 Miniprep 45μl110,6ng/μlaug 31
+pSB1A2LigA (2): Exact blue light promotor ligated with E0240 in pSB1A2 Miniprep 43μl76,7ng/μlaug 31
+pSB1A2LigA (3): Exact blue light promotor ligated with E0240 in pSB1A2 Miniprep 44μl84,8ng/μlaug 31
+pSB1A2LigA (4): Exact blue light promotor ligated with E0240 in pSB1A2 Miniprep 34μl31,7ng/μlaug 31
pSB1A2RBS + GFP + terminatorMiniprep45μl104,3ng/μlaug 31

Key/antikey/lock

part plasmid description status μl left concentration date
/GFP with LVA tagpurifiedjuly 28
/tetR promoter purifiedjuly 28

vanillin synthesis

part plasmid description status μl left concentration date
pSB1A2ech + rbspurified plasmid (oranje)108,8 ng/µlAugust 4
pSB1A2Sam5 + rbs, PstI site removedpurified plasmid (oranje)101,3 ng/µlAugust 5
pSB1A2COMTpurified plasmid (oranje)122,9 ng/µlAugust 5
pSB1A2fcs + rbspurified plasmid (fcs pl.)29 µl57,2 ng/µlAugust 12
pSB1A2Sam5 + rbspurified plasmid (sam5 pl.)31 µl76,0 ng/µlAugust 12
pSB1A2ech + rbspurified plasmid (ech B)42,8 µl96,7 ng/µlAugust 19
pSB1A2ech + rbspurified plasmid (ech C)48 µl105,6 ng/µlAugust 19
pSB1A2fcs + rbspurified plasmid (fcs B)43,6 µl113,4 ng/µlAugust 19
pSB1A2fcs + rbspurified plasmid (fcs C)48 µl90,3 ng/µlAugust 19
pSB1A2Sam5 + rbspurified plasmid (sam5 B)44 µl125,0 ng/µlAugust 19
pSB1A2Sam5 + rbspurified plasmid (sam5 C)48 µl104,2 ng/µlAugust 19
pSB1A2Sam8 + rbspurified plasmid (sam8 B)40,1 µl63,2 ng/µlAugust 19
pSB1A2sam8 + sam5ligation mix (SAMS)August 24
pSB1A2fcs + echligation mix (EF)August 24
pSB1A2fcs + echpurified ligation plasmid (EF I)48 µl53,9 ng/µlAugust 4
pSB1A2fcs + echpurified ligation plasmid (EF II)42 µl39,4 ng/µlAugust 4
pSB1A2fcs + echpurified ligation plasmid (EF III)39,9 µl57,1 ng/µlAugust 4
pSB1A2sam8 + sam5purified ligation plasmid (SAMS I)48 µl76,8 ng/µlAugust 4
pSB1A2sam8 + sam5purified ligation plasmid (SAMS II)35,383,4 ng/µlAugust 4
pSB1A2sam8 + sam5purified ligation plasmid (SAMS III)39,3 µl61,5 ng/µlAugust 4
pSB1A2sam8 + sam5purified ligation plasmid (SAMS II), not purified from gel5 µl August 31
pSB1A2sam8 + sam5purified ligation plasmid (SAMS I), purified from gel25 µl August 31
pSB1A2fcs + echpurified ligation plasmid (EF II), purified from gel5 µl August 31

vanillin receptor

part plasmid description status μl left concentration date
2235 / forward primer for 20μM August 3
2238 / reverse primer for 20μM August 3
2235 / forward primer for 100μM August 3
2238 / reverse primer for 100μM August 3
2242 / forward primer for 20μM August 3
2243 / reverse primer for 20μM August 3
2242 / forward primer for 100μM August 3
2243 / reverse primer for 100μM August 3
2244 / forward primer for 20μM August 3
2245 / reverse primer for 20μM August 3
2244 / forward primer for 100μM August 3
2245 / reverse primer for 100μM August 3
2246 / forward primer for 20μM August 3
2247 / reverse primer for 20μM August 3
2246 / forward primer for 100μM August 3
2247 / reverse primer for 100μM August 3
2288 / forward primer for mutagenesis for 20μM August 8
2289 / reverse primer for mutagenesis for 20μM August 8
2288 / forward primer for mutagenesis for 100μM August 8
2289 / reverse primer for mutagenesis for 100μM August 8
2290 / forward primer for mutagenesis for 20μM August 8
2291 / reverse primer for mutagenesis for 20μM August 8
2290 / forward primer for mutagenesis for 100μM August 8
2291 / reverse primer for mutagenesis for 100μM August 8
2292 / forward primer for mutagenesis for 20μM August 8
2293 / reverse primer for mutagenesis for 20μM August 8
2292 / forward primer for mutagenesis for 100μM August 8
2293 / reverse primer for mutagenesis for 100μM August 8
2294 / forward primer for mutagenesis for 20μM August 8
2295 / reverse primer for mutagenesis for 20μM August 8
2294 / forward primer for mutagenesis for 100μM August 8
2295 / reverse primer for mutagenesis for 100μM August 8

miscellaneous

part plasmid description status μl left concentration date
dNTP mixATP, GTP, TTP, CTP9410μMaug 10
pSB1A2medium constitutieve promoterjuly 23
ampicilline